retatrutide clinical trial results 2025 Timeline: Week-by-Week (48 Weeks) Retatrutide Helped Adults With Obesity

Adam Perlman, MD, MPH, who is the former director of Integrative Health and Wellbeing at the Mayo Clinics Florida campus and former associate vice president for health and wellness at the Duke University Health System

Formulated with science-backed ingredients, this targeted blend is designed to help reduce cravings, curb excessive appetite, and support stubborn belly weight loss when paired with a healthy diet and exercise

A Master Protocol to Investigate Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight, including Knee Osteoarthritis substudy (TRIUMPH-1, NCT05929066)

The 8 mg dose produced mean weight loss of approximately 22.8%, while the 4 mg dose achieved about 17.3% weight reduction